Clinical Trials Browser

Phase 1 × Squamous Cell Carcinoma of Head and Neck × avelumab × Clear all

NCT05222932 2025-08-07

AVENTIL

Phase 1 Active not recruiting

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Melanoma

NCT03498378 2025-04-03

Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Phase 1 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Neoplasms

NCT04601402 2023-08-08

GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy

Phase 1 Completed

GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell

NCT02938273 2019-12-11

Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck